Dr. Priyanka Chhadva, MD

Dr. Chhadva practices at Marshuburn Eye Center in Whittier, California.

Dr. Chhadva's NPI, 1700249554, was assigned on March 30, 2016. Dr. Chhadva graduated from University of Miami, Miller School of Medicine in 2016. Dr. Chhadva holds California license A168158.

Dr. Chhadva's primary practice is Marshuburn Eye Center, at 15925 Whittier Blvd, Whittier, CA 90603-2524. The practice phone is (562) 947-8681.

Dr. Chhadva's primary practice is Marshuburn Eye Center in Whittier, California. Dr. Chhadva is also affiliated with UCI Health - Orange. Dmand AI also links Dr. Chhadva to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chhadva practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Chhadva's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Chhadva is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chhadva's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Chhadva treats.

CMS data shows 1,588 Medicare services from Dr. Chhadva across 13 procedure codes in 2024, for 483 Medicare patients. Medicare paid $110,586 for them.

CMS counts 483 Medicare patients who saw Dr. Chhadva in 2024. The largest group is 75 to 84, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chhadva's median patient age at 71, with 61% women.

In 2024, Dr. Chhadva wrote 248 Medicare Part D claims for 103 patients. 50% of them were for generic drugs. CMS names the drug for 155 of them, across 6 drugs with 11 or more claims each, at $13,059 in total drug cost. In 2023, CMS named 137 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chhadva for performance year 2024, reported individually. Dr. Chhadva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 69 procedures of cataract surgery by Dr. Chhadva, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Chhadva, published from 2015 to 2025. 2015 was the busiest year, with 2. The most frequent topics are Visual Acuity, Corneal Diseases and Dry Eye Syndromes. Dr. Chhadva has published most often in Cornea. Dr. Chhadva's most frequent co-authors are Anat Galor, MD, Sonia H. Yoo, MD and Florence Cabot, MD.

CMS Open Payments shows 18 general payments to Dr. Chhadva from 9 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 93% of the total. Alcon Laboratories Inc paid the most, $288.

Dr. Chhadva graduated from University of Miami, Miller School of Medicine in 2016.

Dr. Chhadva is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.